Pipeline Watch: 11 Approvals And 12 Phase III Trial Readouts In A Double Edition
Executive Summary
A double edition of Pipeline Watch, a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.